GlyHealth-IBD

£0.00

GlyHealth-IBD is the most advanced of our disease-specific GlyHealth variants. It is a prognostic and predictive biomarker of inflammatory bowel disease (IBD).

The test is being designed to support clinical decision-making by gastroenterologists caring for IBD patients and as a complementary biomarker to enhance clinical trials for anti-inflammatory drugs for IBD.

The glycomics patterns we measure in GlyHealth-IBD are early-warning, sub-clinical, prodromal signals of future Inflammatory Bowel Disease flares.

Preliminary studies on over 400 patients showed that GlyHealth-IBD can, from a small (0.2ml) sample of blood, reliably measure:

  1. The severity of an IBD patient’s disease now,
  2. The likely future course of their disease and
  3. The likelihood they would need future treatment escalation up to 18 months from the time of testing.
Read more

Available on backorder

Related products

  • Immunofrailty Test

    Rated 0 out of 5
    £250.00 Add to cart

    Glycan-based test that measures the fitness of your immune system and helps to learn about the nature of your inflammation from a small amount of blood.

  • COVID, glyhealth, glycans, immunofrailty, immunology, immune system Out of stock

    GlyHealth COVID

    Rated 0 out of 5
    £0.00 Read more

    GlyHealth-COVID is being developed to identify immunofrail individuals likely to suffer serious inflammatory episodes if they were to be infected with SARS-Cov-2 virus.